CCEL
CryoCell International Inc
4.00$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +72.2% | -110.7% | – | +37.4% | -11.5% | -55.8% | -25.9% | +258.8% | -49.5% | -49.1% | +183.2% | – | |
| – | -2.4% | -60.7% | +16.9% | +76.4% | +2.1% | +0.2% | +1.3% | +2.7% | -6.6% | +3.6% | +0.4% | – | |
| – | +1.7% | +75.7% | -42.0% | -18.1% | +2.6% | +98.7% | -86.5% | -8.1% | +16.6% | +269.6% | -59.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +650.2% | -131.9% | – | +84.4% | +230.1% | -107.8% | – | – | +268.8% | -112.3% | – | – | |
| – | -49.9% | -73.3% | +486.7% | -88.1% | -55.6% | -56.2% | +0.6% | -37.8% | +73.3% | -0.2% | -51.2% | – | |
| – | -41.5% | -82.8% | +707.7% | -75.8% | +67.6% | -74.2% | +422.7% | – | -126.2% | – | +83.4% | – | |
| – | – | – | – | – | – | – | -40.1% | – | – | – | – | – | |
| – | – | -121.3% | +626.1% | -98.7% | -100.0% | – | – | -8.7% | -100.0% | – | – | – | |
| – | – | – | – | -191.7% | – | -19.8% | +97.8% | – | – | -21.0% | +122.4% | – | |
| – | -270.5% | – | +123.2% | -269.8% | -66.8% | +48.2% | – | -594.8% | -73.3% | -21.0% | +119.3% | – | |
| – | – | – | – | -222.4% | – | -192.9% | – | – | -57.9% | -228.9% | – | – | |
| – | – | -150.0% | – | – | -4.9% | -55.7% | -27.7% | +287.5% | -51.4% | -51.8% | +210.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.